BioSpace News Archive

Lannett Company, Inc. (NYSE: LCI) (“Lannett” or the “Company”) today announced the pricing of $75 million aggregate principal amount of 4.50% convertible senior notes due 2026 (the “Notes”) in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”)

Vitamin Angels, a global public health organization that connects undernourished mothers and children with essential vitamins and minerals, announced its $7.5M commitment to improve global maternal health and birth outcomes by 2022 at the Bill & Melinda Gates Foundation’s Goalkeepers event in New York City today.

Youngevity International, Inc. (NASDAQ:YGYI), a leading multi-channel lifestyle company, today announced the launch of its Hemp FX, phytocannabinoid-rich hemp oil product line, in Japan

Key national experts announce a new unique consulting partnership focusing on due diligence for private equity firms combining deep local analysis with national policy review on regulation and payment.

Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK) (NASDAQ: CHEKW), (NASDAQ: CHEKZ), today announced the appointment of Dr. Vardit Segal as Vice President of Clinical Affairs, effective October 22, 2019.

Xstrahl Medical, global leader in superficial radiotherapy devices to treat non-melanoma skin cancer and dermatological conditions, is spotlighting its RADiant treatment system at the Fall American Osteopathic College of Dermatology (AOCD) meeting in Nashville, Tennesse from September 26th-28th.

Deep Genomics, the leading AI therapeutics company, announced today that its proprietary artificial intelligence-based drug discovery platform has identified a novel treatment target and corresponding drug candidate for Wilson disease, a rare, serious, and potentially life-threatening genetic disorder.

Company Plans to Complete Financing in First Quarter of 2020

The award is through the Broad Agency Announcement (BAA) program to advance Versatope’s universal influenza vaccine candidate.

Combe, Inc., the makers of Vagisil®, announced a partnership with Power to Decide, the campaign to prevent unplanned pregnancy, to provide low-income women access to contraception.